- AttorneyOne.com – Finding An Attorney Online, Just Got Easier

Hospital Risk Managers, Pharmacy and Emergency Medicine healthcare personnel are informed by the FDA that Sodium Bicarbonate Injection, USP, 7.5% and 8.4%, 50 mL Single Dose Vials are recalled because some vials of these lots contain particulates and may cause adverse events including granuloma formation and damage to blood vessels in the lung. Background of [...]

Following the recall of various Injectable USP Products from American Regent, pharmacists and the medical fraternity at large have been alerted of the updates and product details of the affected medical injectables. Background of American Regent Injectable products American Regent is a manufacture that produces, among other medical products, a line of products in therapeutic [...]

April 7, 2010                                                                                                                                                     The FDA has issued a change in reference standard for Heparin Sodium USP; stating that in laboratory tests that they requested it was found that Heparin Sodium, USP made under the new USP (United States Pharmacopeia) Monograph (the ‘new heparin’), contains approximately 10% less anticoagulant (blood thinning) agent compared to heparin [...]